Profile

PurMinds is a neuro-medicine company pursuing breakthrough solutions to neurological disorders by leveraging proven mechanisms of action and neuroplastogens for their ability to promote neuroplasticity and neuro-rejuvenation.

Its lead program (PUR501) is a third generation 5-HT2A partial agonist, non-hallucinogenic neuroplastogen Novel Chemical Entity (NCE) with safe cardiovascular profile, followed by a second generation HDAC6 inhibitor NCE (PUR400 series).

PurMinds NeuroPharma logo

Website

purminds.com

Contact


Event details

Date: September 25 - 27, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

13 in total